Form 8-K - Current report:
SEC Accession No. 0001698530-22-000006
Filing Date
2022-01-18
Accepted
2022-01-18 16:27:00
Documents
13
Period of Report
2022-01-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20220114.htm   iXBRL 8-K 47074
2 EX-10.2 firstamendment_amendedagre.htm EX-10.2 24734
  Complete submission text file 0001698530-22-000006.txt   218120

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20220114.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20220114_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20220114_pre.xml EX-101.PRE 13045
7 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20220114_htm.xml XML 10984
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 22535491
SIC: 2834 Pharmaceutical Preparations